Covid-19 Webinars

RSNA Webinar - Artificial Intelligence: Reflections During COVID-19 and Looking Ahead

Sponsored By:

Sponsored By Zebra Medical Vision
Register

Title: Artificial Intelligence: Reflections During COVID-19 and Looking Ahead

Date: October 29, 2020

Time: 11:00 AM - 12:00 PM Central

Description:
As the medical community expands the use of artificial intelligence as an improvement to efficiency and patient care, this technology continues to find its place in radiology. A panel of experts will consider the impact of AI during the COVID-19 pandemic and discuss current challenges, and opportunities for the future.

Level of Content:
Basic to Intermediate

Primary Audience:
Radiologists and Residents

Secondary Audience:
Radiology trainees

Moderator(s):

  • Matthew Lungren, MD, MPH, Associate Professor of Radiology, Stanford University

Speaker(s):

  • Felipe Campos Kitamura, MD, MSc, Neuroradiologist, UNIFESP, Head of AI, DASA
  • Judy Gichoya, MD, MS, Assistant Professor - Interventional Radiology & Informatics, Emory University
  • Carol C. Wu, MD, Professor of Diagnostic Imaging, MD Anderson Cancer Center
  • Orit Wimpfheimer, MD, Clinical Director, Zebra Medical Vision
  • Sreenivasa R. Kalidindi, MBBS, FRCR, Apollo Radiology International

Price:
Viewing and participating in the live webinar is free to all.

RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.